SuperworthLabcorp profit margin LH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 7.0%
- Operating margin, 12 months
- 10.4%
- Net margin on a year earlier
- +1.3 pts
- Peer median
- 13.4%
Over the twelve months to Jun 30, 2026, Labcorp kept 7.0% of its revenue as net profit, with an operating margin of 10.4% and a gross margin of 28.9%.
Five years earlier its net margin was 17.6%.
The median for 10 diagnostics and research stocks of a similar size is 13.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 6.3% | 9.9% | 28.8% |
| FY2024 | 5.7% | 8.4% | 27.9% |
| FY2023 | 3.4% | 6.0% | 27.7% |
| FY2022 | 9.6% | 11.8% | 30.2% |
| FY2021 | 14.7% | 20.2% | 34.9% |
| FY2020 | 11.1% | 17.5% | 35.4% |
| FY2019 | 7.1% | 11.5% | 28.1% |
| FY2018 | 7.8% | 11.7% | 28.0% |
| FY2017 | 11.9% | 12.7% | 30.0% |
| FY2016 | 7.8% | 13.9% | 33.7% |
| FY2015 | 5.1% | 11.8% | 34.1% |
| FY2014 | 8.5% | 15.1% | 36.6% |
| FY2013 | 9.9% | 17.1% | 38.3% |
| FY2012 | 10.3% | 18.0% | 39.7% |
| FY2011 | 9.4% | 17.1% | 41.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 7.0% | +1.3 pts | 10.4% | |
| Q1 FY26 | 6.7% | +1.1 pts | 10.2% | |
| Q4 FY25 | 6.3% | +0.5 pts | 9.9% | |
| Q3 FY25 | 6.2% | +2.8 pts | 9.7% | |
| Q2 FY25 | 5.7% | +2.1 pts | 8.8% | |
| Q1 FY25 | 5.5% | +2.0 pts | 8.3% | |
| Q4 FY24 | 5.7% | +2.3 pts | 8.4% | |
| Q3 FY24 | 3.4% | −1.7 pts | 5.9% | |
| Q2 FY24 | 3.6% | −3.0 pts | 6.0% | |
| Q1 FY24 | 3.5% | −4.5 pts | 5.8% | |
| Q4 FY23 | 3.4% | −6.1 pts | 6.0% | |
| Q3 FY23 | 5.2% | −7.6 pts | 7.3% |
Against its peers
Companies in Medical - Diagnostics & Research nearest Labcorp's size, closest first, today.
| Company | Profit margin |
|---|---|
| LHLabcorp | 7.0% |
| DGXQuest Diagnostics | 9.2% |
| MTDMettler-Toledo International | 21.9% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| ILMNIllumina | 18.4% |
| IDXXIDEXX Laboratories | 25.0% |
| WATWaters | 3.6% |
| IQVIQVIA | 8.1% |
| AAgilent Technologies | 19.5% |
| BIOBio-Rad Laboratories | 8.6% |
| Peer median | 13.4% |
Where Labcorp ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Labcorp
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.